CI Bio-Revolution Index ETF

The investment objective of the CI Bio Revolution ETF the Fund is to replicate, to the extent reasonably possible the performance of the Solactive Global Genomics Immunology and Medical Revolution CAD Hedged Index NTR the Index. The Fund The Index intends to track the performance of companies that have business operations in the global biotechnology and genomics industry using the ARTIS classification system. The Index hedges foreign currency exposure back to Canadian dollars. The Fund invests in and holds, to the extent reasonably possible, the constituent securities of the Index in substantially the same proportion as they are reflected in the Index. The Fund may use a sampling strategy in selecting its investments to achieve its objective.